{"id":4886,"date":"2019-10-09T13:00:38","date_gmt":"2019-10-09T11:00:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/"},"modified":"2019-10-09T13:00:38","modified_gmt":"2019-10-09T11:00:38","slug":"global-cholera-pipeline-review-h2-2019-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/","title":{"rendered":"Global Cholera Pipeline Review &#8211; H2 2019 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4845442\/cholera-pipeline-review-h2-2019?utm_source=BW&#038;utm_medium=PressRelease&#038;utm_code=tmsvcd&#038;utm_campaign=1306271+-+Global+Cholera+Pipeline+Review+-+H2+2019&#038;utm_exec=anwr281prd\" shape=\"rect\" rel=\"noopener noreferrer\">&#8220;Cholera &#8211; Pipeline Review, H2 2019&#8221;<\/a> drug pipelines has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/5\/ResearchAndMarkets_800px.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg\"><\/a><\/p>\n<p>\nThis latest Pharmaceutical and Healthcare disease pipeline guide Cholera &#8211; Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape.\n<\/p>\n<p>\n<strong>Report Highlights <\/strong>\n<\/p>\n<p>\nThis Pharmaceutical and Healthcare latest pipeline guide Cholera &#8211; Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Cholera (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.\n<\/p>\n<p>\nThe Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies \/Universities \/Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 2 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 1, 6 and 2 molecules, respectively.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nThe pipeline guide provides a snapshot of the global therapeutic landscape of Cholera (Infectious Disease).\n<\/li>\n<li>\nThe pipeline guide reviews pipeline therapeutics for Cholera (Infectious Disease) by companies and universities\/research institutes based on information derived from company and industry-specific sources.\n<\/li>\n<li>\nThe pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.\n<\/li>\n<li>\nThe pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&#038;D brief, MoA &#038; other developmental activities.\n<\/li>\n<li>\nThe pipeline guide reviews key companies involved in Cholera (Infectious Disease) therapeutics and enlists all their major and minor projects.\n<\/li>\n<li>\nThe pipeline guide evaluates Cholera (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.\n<\/li>\n<li>\nThe pipeline guide encapsulates all the dormant and discontinued pipeline projects.\n<\/li>\n<li>\nThe pipeline guide reviews latest news related to pipeline therapeutics for Cholera (Infectious Disease)\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to buy<\/strong>\n<\/p>\n<ul>\n<li>\nProcure strategically important competitor information, analysis, and insights to formulate effective R&#038;D strategies.\n<\/li>\n<li>\nRecognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.\n<\/li>\n<li>\nFind and recognize significant and varied types of therapeutics under development for Cholera (Infectious Disease).\n<\/li>\n<li>\nClassify potential new clients or partners in the target demographic.\n<\/li>\n<li>\nDevelop tactical initiatives by understanding the focus areas of leading companies.\n<\/li>\n<li>\nPlan mergers and acquisitions meritoriously by identifying key players and it&#8217;s most promising pipeline therapeutics.\n<\/li>\n<li>\nFormulate corrective measures for pipeline projects by understanding Cholera (Infectious Disease) pipeline depth and focus of Indication therapeutics.\n<\/li>\n<li>\nDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.\n<\/li>\n<li>\nAdjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered: <\/strong>\n<\/p>\n<ul>\n<li>\nIntroduction\n<\/li>\n<li>\nReport Coverage\n<\/li>\n<li>\nCholera &#8211; Overview\n<\/li>\n<li>\nCholera &#8211; Therapeutics Development\n<\/li>\n<li>\nPipeline Overview\n<\/li>\n<li>\nPipeline by Companies\n<\/li>\n<li>\nPipeline by Universities\/Institutes\n<\/li>\n<li>\nProducts under Development by Companies\n<\/li>\n<li>\nProducts under Development by Universities\/Institutes\n<\/li>\n<li>\nCholera &#8211; Therapeutics Assessment\n<\/li>\n<li>\nAssessment by Target\n<\/li>\n<li>\nAssessment by Mechanism of Action\n<\/li>\n<li>\nAssessment by Route of Administration\n<\/li>\n<li>\nAssessment by Molecule Type\n<\/li>\n<li>\nCholera &#8211; Companies Involved in Therapeutics Development\n<\/li>\n<li>\nAkthelia Pharmaceuticals Ltd\n<\/li>\n<li>\nBeijing Minhai Biotechnology Co Ltd\n<\/li>\n<li>\nNapo Pharmaceuticals Inc\n<\/li>\n<li>\nCholera &#8211; Drug Profiles\n<\/li>\n<li>\nAKT-10082 &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera (trivalent) vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera (whole cell) vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera [serotypes O1 + O139] (bivalent) vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera [strain O1\/El\/Tor\/Ogawa] vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncholera vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nCholvax &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ncrofelemer DR &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\ngram-negative bacterial infections vaccine &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nIMSUTMR-1501 &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nLB-2 &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nPeptide for Cholera and Guillain-Barre Syndrome &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nSmall Molecules for Bacterial Infections &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nSmall Molecules to Inhibit Sialic Acid Permease for Gram Negative Bacterial Infections &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nSynthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections &#8211; Drug Profile\n<\/li>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism Of Action\n<\/li>\n<li>\nR&#038;D Progress\n<\/li>\n<li>\nCholera &#8211; Dormant Projects\n<\/li>\n<li>\nCholera &#8211; Discontinued Products\n<\/li>\n<li>\nCholera &#8211; Product Development Milestones\n<\/li>\n<li>\nFeatured News &#038; Press Releases\n<\/li>\n<li>\nJun 13, 2018: Fast-acting Cholera Vaccine Could Curb Outbreaks\n<\/li>\n<li>\nApr 27, 2016: Hilleman Laboratories Provides Phase I\/II Update on Cholera Vaccine\n<\/li>\n<li>\nFeb 03, 2015: Napo Files Brief on Appeal In Dispute With Salix\n<\/li>\n<li>\nAppendix\n<\/li>\n<li>\nMethodology\n<\/li>\n<li>\nCoverage\n<\/li>\n<li>\nSecondary Research\n<\/li>\n<li>\nPrimary Research\n<\/li>\n<li>\nExpert Panel Validation\n<\/li>\n<li>\nContact Us\n<\/li>\n<li>\nDisclaimer\n<\/li>\n<\/ul>\n<p>\nFor more information about this drug pipelines report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4845442\/cholera-pipeline-review-h2-2019?utm_source=BW&#038;utm_medium=PressRelease&#038;utm_code=tmsvcd&#038;utm_campaign=1306271+-+Global+Cholera+Pipeline+Review+-+H2+2019&#038;utm_exec=anwr281prd\" shape=\"rect\" rel=\"noopener noreferrer\">https:\/\/www.researchandmarkets.com\/r\/qlkrjh<\/a>\n<\/p>\n<div style=\"display:none;\">\n<p>\n\u00a0\n<\/p>\n<\/div>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&#038;sty=20191009005336r1&#038;sid=web01&#038;distro=nx&#038;lang=en\" style=\"width:0;height:0\"><span class=\"bwct31415\"><\/span><\/p>\n<p><b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;&#116;o&#x3a;&#x70;&#x72;&#101;&#115;s&#64;&#x72;&#x65;&#x73;&#101;&#97;r&#x63;&#x68;&#x61;&#110;&#100;&#109;a&#x72;&#x6b;&#x65;&#116;&#115;&#46;c&#x6f;&#x6d;\" shape=\"rect\" rel=\"noopener noreferrer\">&#x70;&#x72;&#101;&#115;s&#x40;&#x72;&#x65;&#115;&#101;a&#x72;&#x63;&#x68;&#97;&#110;d&#x6d;&#x61;&#x72;&#107;&#101;t&#x73;&#x2e;&#x63;&#111;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cholera &#8211; Pipeline Review, H2 2019&#8221; drug pipelines has been added to ResearchAndMarkets.com&#8217;s offering. This latest Pharmaceutical and Healthcare disease pipeline guide Cholera &#8211; Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Report Highlights This Pharmaceutical and Healthcare latest pipeline guide Cholera &#8211; Pipeline Review, H2 2019, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-4886","6":"format-standard","7":"category-allgemein"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cholera &#8211; Pipeline Review, H2 2019&#8221; drug pipelines has been added to ResearchAndMarkets.com&#8217;s offering. This latest Pharmaceutical and Healthcare disease pipeline guide Cholera &#8211; Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Report Highlights This Pharmaceutical and Healthcare latest pipeline guide Cholera &#8211; Pipeline Review, H2 2019, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-09T11:00:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Cholera Pipeline Review &#8211; H2 2019 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2019-10-09T11:00:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/\"},\"wordCount\":919,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005336\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/\",\"name\":\"Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005336\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"datePublished\":\"2019-10-09T11:00:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005336\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005336\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Cholera Pipeline Review &#8211; H2 2019 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cholera &#8211; Pipeline Review, H2 2019&#8221; drug pipelines has been added to ResearchAndMarkets.com&#8217;s offering. This latest Pharmaceutical and Healthcare disease pipeline guide Cholera &#8211; Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Report Highlights This Pharmaceutical and Healthcare latest pipeline guide Cholera &#8211; Pipeline Review, H2 2019, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2019-10-09T11:00:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Cholera Pipeline Review &#8211; H2 2019 &#8211; ResearchAndMarkets.com","datePublished":"2019-10-09T11:00:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/"},"wordCount":919,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/","name":"Global Cholera Pipeline Review - H2 2019 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","datePublished":"2019-10-09T11:00:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20191009005336\/en\/371054\/21\/ResearchAndMarkets_800px.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-cholera-pipeline-review-h2-2019-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Cholera Pipeline Review &#8211; H2 2019 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=4886"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4886\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=4886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=4886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=4886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}